AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer activity. AZD3514 is being evaluated in a Phase I clinical trial in patients with castrate-resistant prostate cancer.

June 21, 2017

prudect name : AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer activity. AZD3514 is being evaluated in a Phase I clinical trial in patients with castrate-resistant prostate cancer.
AZD-3514

Synonyms: CAS NO: 1240299-33-5Molecular Formula: C₂₅H₃₂F₃N₇O₂Molecular Weight: 519.56Purity: 98% minSolubility: In DMSOStorage: -20°C

852808-04-9 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18502303